OpenAlex
PricingAboutJobs
Log inGet started
Work

Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone

HTML

Year: 2011
Type: article
Source: Arthritis & Rheumatism
DOI: 10.1002/art.30385
Authors: M. Marenzana, K. Greenslade, A. Eddleston, R. Okoye, D. Marshall, A. Moore, M. K. Robinson
Institution: UCB Pharma (United Kingdom)
Language: English

Topic: Bone health and osteoporosis research
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Keywords: sclerostin, dexamethasone, glucocorticoid-induced osteoporosis, linear growth, bone strength, trabecular bone, cortical bone, bone turnover markers, osteocalcin, tartrate-resistant acid phosphatase, sclerosteosis, bone formation
SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, UCB Celltech
OpenAlex ID: W2057472181
FWCI: 9.126
Cites: 39
Cited by: 74
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security